Press release
2025 Adult Malignant Glioma Therapeutics Market Outlook: Key Indicators Shaping Growth Through 2034
Adult Malignant Glioma Therapeutics
What Will the Adult Malignant Glioma Therapeutics Industry Market Size Be by 2025?
The market for adult malignant glioma therapeutics has experienced swift expansion in the past few years. The market value, presently at $2.25 billion in 2024, is projected to rise to $2.48 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.4%. This development over the historic duration is due to a surge in incidence rates, initiatives advocating for patients, and the growth in personalized medical treatments.
What's the Long-Term Growth Forecast for the Adult Malignant Glioma Therapeutics Market Size Through 2029?
In the coming years, the adult malignant glioma therapeutics market is forecasted to witness significant expansion. The market is set to reach $3.55 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.4%. This predicted growth during the forecast period can be credited to advancements in immunotherapy and targeted therapies, the discovery of biomarkers, the application of liquid biopsies, and the introduction of expanded access programs. The forecast period is also expected to see major trends like the development of drugs with a focus on the patient, the fast-track and breakthrough designation, progress in drug delivery systems, collaborative research initiatives, and the introduction of artificial intelligence.
View the full report here:
https://www.thebusinessresearchcompany.com/report/adult-malignant-glioma-therapeutics-global-market-report
What Are the Key Growth Drivers Fueling the Adult Malignant Glioma Therapeutics Market Expansion?
The rising incidences of brain tumors are anticipated to fuel the adult malignant glioma therapeutics market expansion. A brain tumor is a non-standard mass of tissue where the typical biological regulations governing cells seem not to impede the unrestrained growth and cell multiplication. Adult malignant glioma is a variant of the brain tumor consisting of cells that multiply extraordinarily and unrestrainedly. The treatment of adult malignant glioma manages brain tumors using a combination of surgery, radiation therapy, and chemotherapy. For example, the American Cancer Society, a US nonprofit cancer advocacy organization, noted in January 2023 that brain and nervous system cancer cases had escalated to 24,810 in 2023, a boost of 3.85% from 23,890 in 2020. Thus, the escalating incidences of brain tumors are propelling the adult malignant glioma therapeutics market. An important catalyst for progress in Adult Malignant Glioma Therapeutics is governmental funding.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13178&type=smp
What Are the Key Trends Driving Adult Malignant Glioma Therapeutics Market Growth?
Leading firms in the adult malignant glioma therapeutics market are exploring new ways to improve customer service through the development of novel products such as small molecule targeted degraders. These are drugs that utilize small molecules to promote the degradation of specific proteins by focusing on the protein of interest (POI) and an E3 ubiquitin ligase. Beactica Therapeutics AB, a precision oncology company based in Sweden, for instance, obtained orphan drug designation approval from the U.S. Food and Drug Administration (FDA) in February 2023 for BEA-17, a treatment for glioblastoma (GBM). BEA-17 is a type of small molecule targeted degrader which acts on the epigenetic enzyme LSD1 and its co-factor CoREST, both known to be involved in the development of various cancers including GBM. By degrading LSD1 and CoREST, BEA-17 enables the reactivation of tumor suppressor genes and limits the growth of cancer cells.
How Is the Adult Malignant Glioma Therapeutics Market Segmented?
The adult malignant glioma therapeutics market covered in this report is segmented -
1) By Type Of Disease: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma, Other Types
2) By Therapy: Chemotherapy, Targeted Therapy, Radiotherapy, Other Therapies
3) By End-User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers, Other End Users
Subsegments:
1) By Glioblastoma Multiforme: Standard Treatments, Experimental Therapies
2) By Anaplastic Astrocytoma: Chemotherapy Options, Targeted Therapies
3) By Anaplastic Oligodendroglioma: Radiation Therapy, Combination Therapies
4) By Anaplastic Oligoastrocytoma: Surgical Interventions, Adjuvant Therapies
5) By Other Types: Rare Gliomas, Emerging Therapies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13178&type=smp
Which Companies Are Leading the Charge in Adult Malignant Glioma Therapeutics Market Innovation?
Major companies operating in the adult malignant glioma therapeutics market report are Johnson & Johnson Private Limited, Pfizer Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Allergan PLC, AbbVie Inc., Novartis AG, Bayer AG, Merck & Co Inc., GlaxoSmithKline PLC, Bristol-Myers Squibb Company, Abbott Laboratories, AstraZeneca PLC, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., GT Medical Technologies Inc., Lupin Limited, Mylan NV, Sanofi SA, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Genetech Inc., Amneal Pharmaceuticals LLC, Emcure Pharmaceuticals Limited, Novocure Ltd., Arbour Pharmaceuticals LLC, Basilea Pharmaceuticals Ltd.
Which Regions Are Leading the Global Adult Malignant Glioma Therapeutics Market in Revenue?
North America was the largest region in the adult malignant glioma therapeutics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adult malignant glioma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13178
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025 Adult Malignant Glioma Therapeutics Market Outlook: Key Indicators Shaping Growth Through 2034 here
News-ID: 4117922 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Adult
Adult Website Development (AWD) Announces Expanded Web Solutions for the Adult E …
Adult Website Development (AWD), a specialized Adult Website Development Company, today announced the expansion of its professional web design and development services tailored exclusively for the adult entertainment industry. The company continues to strengthen its position as a trusted technology partner by delivering secure, scalable, and performance-driven digital platforms for adult businesses worldwide.
With a deep understanding of industry-specific challenges, AWD offers end-to-end solutions including custom adult website design, full-stack development,…
Adult Animation Market constantly growing to See Bigger Picture | Adult Swim, Ne …
The latest study released on the Global Adult Animation Market by HTF MI Research evaluates market size, trend, and forecast to 2033. The Adult Animation market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Key Players…
Adult mitochondrial epilepsy presentation
Mitochondrial epilepsy is a rare but severe neurological condition caused by genetic mutations that impair mitochondrial function, disrupting cellular energy production in the brain. Patients often present with seizures, developmental delays, and neurodegeneration. It is closely associated with broader mitochondrial diseases such as MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) and Leigh syndrome.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72869
Due to its rarity and complexity, treatment options…
Prominent Adult Entertainment Market Trend for 2025: AI-Driven Innovations In Ad …
"What Are the Projected Growth and Market Size Trends for the Adult Entertainment Market?
In recent times, the adult entertainment market has seen substantial expansion. The market size is set to increase from $65.95 billion in 2024 to $71.95 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.1%. The notable growth during the historic period is owed largely to a combination of factors. These include a wider acceptance…
Adult Diapers Market - A New Standard of Care: Transformative Diapers Redefining …
Newark, New Castle, USA: The "Adult Diapers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Adult Diapers Market: https://www.growthplusreports.com/report/adult-diapers-market/7749
This latest report researches the industry structure, sales, revenue,…
Adult Toys Market
The global Adult Toys market is valued at 16200 million US$ in 2018 and will reach 34100 million US$ by the end of 2025, growing at a CAGR of 9.8% during 2019-2025.
The Market Insights Reports has published the obtainability of a new statistical data to its repository titled as, Adult Toys Market. The report provides useful insights into a wide range of business aspects such as pillars, features, sales strategies,…
